Riverain Re-Brands Imaging Software Suite

Lena Kauffman | | Radiology Business | Business Intelligence
Miamisburg, Ohio-based Riverain Technologies is rebranding three of its chest x-ray software applications. The company is pinning this announcement to the annual meeting of the Society of Thoracic Radiology this week. The Riverain SoftView application, which enhances standard x-ray images for the purposes of detecting lung nodules, will now be known as ClearRead Bone Suppression. ClearRead +Detect is the new name of Riverain OnGuard computer-aided detection software, “which circles potential lung nodules on a bone-suppressed X-ray image for further evaluation by a radiologist,” according to a Riverain press release. Finally, Riverain DeltaView software will become ClearRead +Compare, an application that “electronically aligns two chest X-ray images taken on the same patient at different times, creating a subtraction image [that]…accentuates changes over time,” according to the same release.

Lena Kauffman,

Contributor

Lena Kauffman is a contributing writer based in Ann Arbor, Michigan.

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.